Lamisil Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 390

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Lamisil General Information

Description

An over-the-counter (OTC) brand for the treatment of fungal infections. The brand specializes in addressing fungal issues.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Brentford
  • England, United Kingdom
Primary Industry
Buildings and Property
Acquirer
Corporate Office
  • Brentford
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lamisil Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lamisil‘s full profile, request access.

Request a free trial

Lamisil Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lamisil Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lamisil‘s full profile, request access.

Request a free trial

Lamisil FAQs

  • Where is Lamisil headquartered?

    Lamisil is headquartered in Brentford, United Kingdom.

  • What is the size of Lamisil?

    Lamisil has 390 total employees.

  • What industry is Lamisil in?

    Lamisil’s primary industry is Buildings and Property.

  • Is Lamisil a private or public company?

    Lamisil is a Private company.

  • What is the current valuation of Lamisil?

    The current valuation of Lamisil is .

  • What is Lamisil’s current revenue?

    The current revenue for Lamisil is .

  • Who are Lamisil’s investors?

    Haleon has invested in Lamisil.

  • When was Lamisil acquired?

    Lamisil was acquired on 31-Oct-2023.

  • Who acquired Lamisil?

    Lamisil was acquired by Karo Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process